Pharmacy News

Today's Pharmaceutical and Pharmacy News

Daily News Topic:

FDA News

3/10/10 - BOTOXÂ® (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults

Allergan, Inc. today announced that the United States Food and Drug Administration has approved BOTOXÂ® for the treatment of increased muscle stiffness in the elbow, wrist and fingers in adults with upper limb spasticity. Spasticity is a debilitating condition impacting approximately 1 million Americans1, many of whom suffer from spasticity in the

3/9/10 - ETEX Corporation Announces FDA Clearance and Launch of Carrigen(R) Porous Bone Substitute Material

CAMBRIDGE, Mass., March 9ETEX Corporation, an advanced biomaterials company, announced today that the FDA has granted 510 clearance of CarriGenÂ® Porous Bone Substitute Material. CarriGen is indicated as a bone void filler of the pelvis, extremities and spine, including posterolateral spine fusion.

3/9/10 - FDA approves Botox for elbow, wrist, finger spasms

WASHINGTON -- The Food and Drug Administration said Tuesday it approved Allergan's botulinum-based drug Botox to treat spasms of the elbow, wrist and fingers. Botox is most famous for it's ability to smooth frown lines on aging foreheads, but the drug has long been used to treat neck spasms, eye muscle disorders and excessive underarm sweating.

3/9/10 - FDA approves Botox for spasms in lower arm muscles

WASHINGTON -- The Food and Drug Administration says it has approved Allergan's drug Botox to treat spasms of the elbow, wrist and fingers. Botox is most famous for it's ability to smooth frown lines, but the drug has long been used to treat neck spasms and other muscle disorders.

3/9/10 - FDA Approves Botox to Treat Spasticity in Flexor Muscles of the Elbow, Wrist and Fingers

SILVER SPRING, Md., March 9The U.S. Food and Drug Administration today approved Botox to treat spasticity in the flexor muscles of the elbow, wrist, and fingers in adults.

3/9/10 - FDA Clears GeNO LLC Investigational New Drug Application for Nitric Oxide Delivery System

COCOA, Fla., March 9GeNO LLC a privately held, advanced development-stage technology company, today announced that the U.S. Food and Drug Administration has granted clearance of Â its Investigational New Drug application for its stand-alone gas cylinder Nitrosyl Delivery Platform. GeNO's stand-alone gas cylinder stores premixed nitric oxide as nitr

Chain Drug Review

Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.

Featured Article from Chain Drug Review:

AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more